Skye Bioscience, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Skye Bioscience, Inc. (SKYE) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.11 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-03-10
- Skye Bioscience, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 8.11M shares, a 20.28% increase from fiscal 2024.
- Skye Bioscience, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 6.74M shares, a 20.38% increase from fiscal 2023.
- Skye Bioscience, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 5.60M shares, a 465.86% increase from fiscal 2022.
- Skye Bioscience, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 989.83K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|
| 2025-12-31 | 8.11M shares 10-K · filed 2026-03-10 |
| 2024-12-31 | 6.74M shares 10-K · filed 2026-03-10 |
| 2023-12-31 | 5.60M shares 10-K · filed 2025-03-20 |
| 2022-12-31 | 989.83K shares 10-K · filed 2024-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |